Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma

30 May 2021

Abstract excerpt

The analysis of cfDNA has been applied as a liquid biopsy in several malignancies. However, its value in the diagnosis and prognosis of cholangiocarcinoma (CCA) have not been well defined. We aimed to investigate the diagnostic and prognostic values of cfDNA level and tumor-specific mutation in circulating DNA (ctDNA) in CCA. The plasma cfDNA levels from 62 CCA patients, 33 benign biliary disease (BBD) patients...

Topics

Join the communities discussing this publication.

Cancer Genomics and Diagnostics
Cholangiocarcinoma and Gallbladder Cancer Studies
Tumors and Oncological Cases

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 34070951
DOI: 10.3390/diagnostics11060999

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnostic and Prognostic Value of Circulating Cell-Free DNA for CholangiocarcinomaPMID 34070951Read ↗

Targeting the Sequences of Circulating Tumor DNA of Cholangiocarcinomas and Its Applications and Limitations in Clinical Practice.Semantic proximity Read ↗

Circulating Cell-Free DNA-Based Comprehensive Molecular Analysis of Biliary Tract Cancers Using Next-Generation SequencingSemantic proximity Read ↗

Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic informationSemantic proximity Read ↗

Identification of whole-genome mutations and structural variations of bile cell-free DNA in cholangiocarcinoma.Semantic proximity Read ↗

Bile cell‑free DNA as a novel and powerful liquid biopsy for detecting somatic variants in biliary tract cancerSemantic proximity Read ↗

Bile liquid biopsy is a useful modality for molecular diagnosis of cancerous tumors in pancreatic head lesionsSemantic proximity Read ↗

KRAS Mutations in Cholangiocarcinoma: Prevalence, Prognostic Value, and KRAS G12/G13 Detection in Cell-Free DNA.Semantic proximity Read ↗

Circulating Tumor DNA in Biliary Tract Cancer: Current Evidence and Future PerspectivesSemantic proximity Read ↗

Biomarkers for the Management of Cholangiocarcinoma: Unveiling New Horizons for Precision TherapySemantic proximity Read ↗

Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and OutlookSemantic proximity Read ↗

Cell-free DNA from bile outperformed plasma as a potential alternative to tissue biopsy in biliary tract cancer.Semantic proximity Read ↗

Precision Medicine in Cholangiocarcinoma: Past, Present, and FutureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.